Legal Representation
Attorney
Karl M. Zielaznicki, Esq.
USPTO Deadlines
Next Deadline
2084 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250930)
Due Date
September 30, 2031
Grace Period Ends
March 30, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 30, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 30, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 5, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Sep 5, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 31, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 9, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 31, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 9, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Dec 3, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 1, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 1, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 1, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 22, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 22, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 2, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 12, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 15, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 15, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely, cerebrotendinous xanthomatosis (CTX)
First Use Anywhere:
Apr 3, 2025
First Use in Commerce:
Apr 3, 2025
Classification
International Classes
005